2024-11-15 22:43:52
CStone announces first patient dosed in Phase I study in China for MEK inhibitor CS3006
Health/ 2023-07-22
CStone announces first patient dosed in ...

SUZHOU,China,Oct. 30,2018-- CStone Pharmaceuticals (CStone) today announced the initiation in China of a Phase I clinical trial for CS3006,a...

L.E.A.F. Pharmaceuticals Receives Positive US FDA Feedback and Comprehensive Roadmap for Clinical Development as well as Registration of its Four Lead Novel Anticancer Drugs
Health/ 2023-07-22
L.E.A.F. Pharmaceuticals Receives Positi...

US FDA further indicates that one of the four drugs may be eligible for registration via 505(b)(2) Regulatory Pathway

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release